Medical Bulletin 03/ September /2024 Dr. Garima Soni3 Sept 2024 3:00 PM ISTHere are the top medical news of the day:Does Continuing Beta-Blockers After a Heart Attack Make a Difference? New Study Sheds Lights New research...
Finerenone Reduces Heart Failure Events and Cardiovascular Deaths: FINEARTS-HF trial Dr. Garima Soni3 Sept 2024 9:00 AM ISTRecent research presented at ESC Congress 2024 reveals that finerenone decreased the incidence of heart failure events and cardiovascular deaths in...
FINEARTS-HF Study Shows Finerenone Cuts CV death and Heart Failure Events in HFmrEF/HFpEF Patients Medha Baranwal30 Aug 2024 9:00 AM ISTUSA: Topline results from the FINEARTS-HF trial have revealed that finerenone (Kerendia), a nonsteroidal selective mineralocorticoid receptor...
Medical Bulletin 07/ August/ 2024 Dr. Nandita Mohan7 Aug 2024 3:00 PM ISTHere are the top medical news for the day:New Study Reveals Link Between Obesity and Increased Risk of Heart FailureA recent study led by Johns...
Study shows SGLT2i or Finerenone Added to RAAS Inhibitors Offers Kidney and Heart Protection for Diabetics with CKD Dr. Nandita Mohan7 Aug 2024 8:00 AM ISTType 2 diabetes (T2D) is the leading cause of end-stage kidney disease (ESKD) globally. The presence of both T2D and CKD poses a major public health...
Add on SGLT2i or finerenone to RAAS inhibitor may provide kidney and CV protection in diabetics with CKD: Study Dr. Shravani Dali5 Aug 2024 9:00 AM ISTAdd on SGLT2i or finerenone to RAAS inhibitor may provide kidney and CV protection in diabetics with CKD suggests BMC nephrology.Given the substantial...
Finerenone and dapagliflozin combo significantly reduced albuminuria in non-diabetic CKD patients: Study Aditi20 March 2024 7:30 PM ISTThe effectiveness of dapagliflozin and finerenone in reducing albuminuria and slowing the progression of chronic kidney disease (CKD) has been...
Sun Pharma gets non-exclusive rights to market second brand of Finerenone in India Ruchika Sharma19 Jan 2024 11:17 AM ISTBayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa.
Breakthrough Treatment with finerenone for Advanced Kidney Disease and Diabetes Cost-Effective Dr.Niharika Harsha B21 Dec 2023 10:00 PM ISTIn the Netherlands, where the healthcare system grapples with the staggering burden of over one million patients combating type 2 diabetes (T2D), a...
Finerenone arrests CKD progression by effecting early reduction of albuminuria in diabetes patients Medha Baranwal11 Dec 2023 10:30 AM ISTUSA: Early albuminuria reduction with finerenone (Kerendia) accounted for a large proportion of the treatment effect against chronic kidney disease...
New Kerendia data show impact of early albuminuria reduction in patients with chronic kidney disease, type 2 diabetes: Bayer Ruchika Sharma4 Nov 2023 3:04 PM ISTBerlin: Bayer has announced new late-breaking Kerendia (finerenone) data from FIDELITY, a prespecified pooled analysis of the Phase III...
Bayer Kerendia granted expanded indication in EU for broad range of patients with chronic kidney disease, type 2 diabetes Ruchika Sharma12 Feb 2023 3:41 PM ISTKerendia is a non-steroidal, selective mineralocorticoid receptor (MR) antagonist that has been shown to block harmful effects of MR overactivation.
